SOD1 knockout mice exhibit early onset sarcopenia and increased incidence of hepatocarcinoma16, and reports of rapid disease progression and early death of patients with homozygous mutations for SOD1 have raised concern over the consequences of targeting WT SOD117–19. This evidence concerns the gene SOD1 and sarcopenia.